Other

Remainder of Fiscal Year 2024

Medtronic Remainder of Fiscal Year 2024 decreased by 52.1% to $405.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $414.00M to $405.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ3 2016
Last reportedQ3 2026Feb 24, 2026
Metric ID: remainder_2024

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$1.29B$862.00M$430.00M$1.26B$839.00M$421.00M$1.26B$836.00M$419.00M$1.23B$824.00M$414.00M$1.30B$846.00M$405.00M
QoQ Change-33.0%-50.1%+193.3%-33.5%-49.8%+198.3%-33.4%-49.9%+192.8%-32.8%-49.8%+214.7%-35.1%-52.1%
YoY Change-1.9%-2.7%-2.1%-0.4%-0.4%-0.5%-2.3%-1.4%-1.2%+6.2%+2.7%-2.2%
Range$405.00M$1.30B
CAGR-28.1%
Avg YoY Growth-0.5%
Median YoY Growth-1.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Medtronic's remainder of fiscal year 2024?
Medtronic (MDT) reported remainder of fiscal year 2024 of $405.00M in Q4 2025.
How has Medtronic's remainder of fiscal year 2024 changed year-over-year?
Medtronic's remainder of fiscal year 2024 decreased by 2.2% year-over-year, from $414.00M to $405.00M.